EU Anti-Competition Crackdown Boosts Access To Affordable Drugs, Commission Finds
A report from the European Commission highlights how the enforcement of pharmaceutical antitrust rules between 2018 and 2022 increased the availability of fairly priced innovative medicines in the bloc.
